Watson Reaches Deal With J&J For Concerta Generic
Johnson & Johnson has inked a deal giving Watson Laboratories Inc. a window to distribute an authorized generic version of its blockbuster attention deficit hyperactivity disorder treatment Concerta while the company...To view the full article, register now.
Already a subscriber? Click here to view full article